PTCT - PTC Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PTCT is currently covered by 16 analysts with an average price target of $47.9. This is a potential upside of $8.67 (22.1%) from yesterday's end of day stock price of $39.23.

PTC Therapeutics's activity chart (see below) currently has 136 price targets and 212 ratings on display. The stock rating distribution of PTCT is 19.51% SELL, 37.8% HOLD and 42.68% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.27% with an average time for these price targets to be met of 192.17 days.

Highest price target for PTCT is $64, Lowest price target is $26, average price target is $47.9.

Most recent stock forecast was given by GENA WANG from BARCLAYS on 14-Nov-2024. First documented stock forecast 14-Feb-2014.

Currently out of the existing stock ratings of PTCT, 16 are a SELL (19.51%), 31 are a HOLD (37.8%), 35 are a BUY (42.68%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$45

$5.77 (14.71%)

$43

3 days ago
(14-Nov-2024)

10/14 (71.43%)

$2.62 (6.18%)

269

Buy

$48

$8.77 (22.36%)

$44

9 days ago
(08-Nov-2024)

10/13 (76.92%)

$3.72 (8.40%)

174

Hold

$45

$5.77 (14.71%)

$32

1 months 6 days ago
(11-Oct-2024)

7/9 (77.78%)

$6 (15.38%)

50

Hold

1 months 7 days ago
(10-Oct-2024)

3/6 (50%)

$16.29 (42.08%)

227

Hold

$34

$-5.23 (-13.33%)

$28

1 months 13 days ago
(04-Oct-2024)

18/23 (78.26%)

$-1.1 (-3.13%)

116

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PTCT (PTC Therapeutics) average time for price targets to be met?

On average it took 192.17 days on average for the stock forecasts to be realized with a an average price target met ratio 51.27

Which analyst has the current highest performing score on PTCT (PTC Therapeutics) with a proven track record?

ALETHIA YOUNG

Which analyst has the most public recommendations on PTCT (PTC Therapeutics)?

Alethia Young works at CANTOR FITZGERALD and has 5 price targets and 5 ratings on PTCT

Which analyst is the currently most bullish on PTCT (PTC Therapeutics)?

Kristen Kluska with highest potential upside - $24.77

Which analyst is the currently most reserved on PTCT (PTC Therapeutics)?

Heather Behanna with lowest potential downside - -$27.23

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?